A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers

Name: A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hiv infections

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 463758
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.